These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
75 related articles for article (PubMed ID: 20043907)
1. Abeta(25-35) as proxyholder for amyloidogenic peptides: in vivo evidence. Gulyaeva NV; Stepanichev MY Exp Neurol; 2010 Mar; 222(1):6-9. PubMed ID: 20043907 [No Abstract] [Full Text] [Related]
2. Subcellular and metabolic examination of amyloid-beta peptides in Alzheimer disease pathogenesis: evidence for Abeta(25-35). Kaminsky YG; Marlatt MW; Smith MA; Kosenko EA Exp Neurol; 2010 Jan; 221(1):26-37. PubMed ID: 19751725 [TBL] [Abstract][Full Text] [Related]
3. Alzheimer's amyloid beta-peptide (1-42): involvement of methionine residue 35 in the oxidative stress and neurotoxicity properties of this peptide. Butterfield DA; Bush AI Neurobiol Aging; 2004; 25(5):563-8. PubMed ID: 15172731 [TBL] [Abstract][Full Text] [Related]
4. Mutations in amyloid precursor protein and presenilin-1 genes increase the basal oxidative stress in murine neuronal cells and lead to increased sensitivity to oxidative stress mediated by amyloid beta-peptide (1-42), HO and kainic acid: implications for Alzheimer's disease. Mohmmad Abdul H; Sultana R; Keller JN; St Clair DK; Markesbery WR; Butterfield DA J Neurochem; 2006 Mar; 96(5):1322-35. PubMed ID: 16478525 [TBL] [Abstract][Full Text] [Related]
5. Aging, gender and APOE isotype modulate metabolism of Alzheimer's Abeta peptides and F-isoprostanes in the absence of detectable amyloid deposits. Yao J; Petanceska SS; Montine TJ; Holtzman DM; Schmidt SD; Parker CA; Callahan MJ; Lipinski WJ; Bisgaier CL; Turner BA; Nixon RA; Martins RN; Ouimet C; Smith JD; Davies P; Laska E; Ehrlich ME; Walker LC; Mathews PM; Gandy S J Neurochem; 2004 Aug; 90(4):1011-8. PubMed ID: 15287908 [TBL] [Abstract][Full Text] [Related]
6. Amyloid peptides in different assembly states and related effects on isolated and cellular proteasomes. Cecarini V; Bonfili L; Amici M; Angeletti M; Keller JN; Eleuteri AM Brain Res; 2008 May; 1209():8-18. PubMed ID: 18400214 [TBL] [Abstract][Full Text] [Related]
8. Effects of memantine on soluble Alphabeta(25-35)-induced changes in peptidergic and glial cells in Alzheimer's disease model rat brain regions. Arif M; Chikuma T; Ahmed MM; Nakazato M; Smith MA; Kato T Neuroscience; 2009 Dec; 164(3):1199-209. PubMed ID: 19733635 [TBL] [Abstract][Full Text] [Related]
9. Cell biology: infectious Alzheimer's disease? Riek R Nature; 2006 Nov; 444(7118):429-31. PubMed ID: 17122841 [No Abstract] [Full Text] [Related]
10. The effect of intrahippocampal beta amyloid (1-42) peptide injection on oxidant and antioxidant status in rat brain. Cetin F; Dincer S Ann N Y Acad Sci; 2007 Apr; 1100():510-7. PubMed ID: 17460216 [TBL] [Abstract][Full Text] [Related]
11. Abeta(31-35) peptide induce apoptosis in PC 12 cells: contrast with Abeta(25-35) peptide and examination of underlying mechanisms. Misiti F; Sampaolese B; Pezzotti M; Marini S; Coletta M; Ceccarelli L; Giardina B; Clementi ME Neurochem Int; 2005 Jun; 46(7):575-83. PubMed ID: 15843052 [TBL] [Abstract][Full Text] [Related]
12. The amyloid-beta25-35 injection into the CA1 region of the neonatal rat hippocampus impairs the long-term memory because of an increase of nitric oxide. Díaz A; De Jesús L; Mendieta L; Calvillo M; Espinosa B; Zenteno E; Guevara J; Limón ID Neurosci Lett; 2010 Jan; 468(2):151-5. PubMed ID: 19879921 [TBL] [Abstract][Full Text] [Related]
13. Why is the amyloid beta peptide of Alzheimer's disease neurotoxic? Rauk A Dalton Trans; 2008 Mar; (10):1273-82. PubMed ID: 18305836 [TBL] [Abstract][Full Text] [Related]
14. Soluble amyloid beta-peptide and myelin basic protein strongly stimulate, alone and in synergism with combined proinflammatory cytokines, the expression of functional nitric oxide synthase-2 in normal adult human astrocytes. Chiarini A; Dal Pra I; Menapace L; Pacchiana R; Whitfield JF; Armato U Int J Mol Med; 2005 Nov; 16(5):801-7. PubMed ID: 16211247 [TBL] [Abstract][Full Text] [Related]
15. Role of peroxynitrite in the vasoactive and cytotoxic effects of Alzheimer's beta-amyloid1-40 peptide. Paris D; Parker TA; Town T; Suo Z; Fang C; Humphrey J; Crawford F; Mullan M Exp Neurol; 1998 Jul; 152(1):116-22. PubMed ID: 9682018 [TBL] [Abstract][Full Text] [Related]
17. A model for studying Alzheimer's Abeta42-induced toxicity in Drosophila melanogaster. Finelli A; Kelkar A; Song HJ; Yang H; Konsolaki M Mol Cell Neurosci; 2004 Jul; 26(3):365-75. PubMed ID: 15234342 [TBL] [Abstract][Full Text] [Related]
19. Methionine 35 oxidation reduces toxic effects of the amyloid beta-protein fragment (31-35) on human red blood cell. Clementi ME; Martorana GE; Pezzotti M; Giardina B; Misiti F Int J Biochem Cell Biol; 2004 Oct; 36(10):2066-76. PubMed ID: 15203119 [TBL] [Abstract][Full Text] [Related]
20. An amyloid-beta protofibril-selective antibody prevents amyloid formation in a mouse model of Alzheimer's disease. Lord A; Gumucio A; Englund H; Sehlin D; Sundquist VS; Söderberg L; Möller C; Gellerfors P; Lannfelt L; Pettersson FE; Nilsson LN Neurobiol Dis; 2009 Dec; 36(3):425-34. PubMed ID: 19703562 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]